C12N 2506/45
From artificially induced pluripotent stem cells
Official title: from artificially induced pluripotent stem cells
C12N2506/45 (From artificially induced pluripotent stem cells) appears on 967 US grants and 2,590 published applications in this corpus.
Search patents in C12N- Granted patents
- 967
- Published applications
- 2,590
- Assignees
- 780
- Inventors
- 4,352
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 3 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 1 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 11 |
| 2011 | 0 | 25 |
| 2012 | 1 | 28 |
| 2013 | 8 | 57 |
| 2014 | 16 | 55 |
| 2015 | 32 | 69 |
| 2016 | 42 | 114 |
| 2017 | 42 | 109 |
| 2018 | 72 | 137 |
| 2019 | 68 | 153 |
| 2020 | 72 | 221 |
| 2021 | 82 | 219 |
| 2022 | 87 | 278 |
| 2023 | 89 | 268 |
| 2024 | 117 | 294 |
| 2025 | 135 | 300 |
| 2026 | 103 | 245 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Induced pluripotent stem cell derived glial enriched progenitor cells for the treatment of white matter stroke6 Oct 2026US 12,751,976 B2The Regents of the University of California
- Production method for stage 5 neurons6 Oct 2026US 12,753,386 B2Ricoh Company, Ltd.
- Haematopoietic stem/progenitor cells29 Sep 2026US 12,747,424 B2Murdoch Childrens Research Institute
- Gene-therapy vectors for treating cardiomyopathy29 Sep 2026US 12,747,453 B2
- Complex microfluidic models for ALS including NF biomarkers for ALS research and drug development29 Sep 2026US 12,748,102 B2Cedars-Sinai Medical Center
- Intra-striatal co-transplantation of autologous treg and mda cells in parkinson's disease cell therapy8 Oct 2026US 2026/0306543 A1The McLean Hospital Corporation
- Protocol for maturation of 3D engineered heart tissue8 Oct 2026US 2026/0308527 A1
- Micropattern-assisted generation of tissue8 Oct 2026US 2026/0308533 A1
- Universal treatment of down syndrome1 Oct 2026US 2026/0294978 A1DEI Biopharma
- Cryopreserved endocrine cells that express chromogranin a1 Oct 2026US 2026/0294981 A1ViaCyte, Inc.
Most cited
By later US patents
- In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells86US 8,859,286 B2ViaCyte, Inc. · 2014
- Cell compositions derived from dedifferentiated reprogrammed cells51US 9,109,245 B2ViaCyte, Inc. · 2015
- SC-β cells and compositions and methods for generating the same50US 10,030,229 B2President and Fellows of Harvard College · 2018
- Differentiation of pluripotent cells37US 8,372,642 B2Cellular Dynamics International, Inc. · 2013
- Methods and systems for converting precursor cells into gastric tissues through directed differentiation27US 10,174,289 B2Children's Hospital Medical Center · 2019